K KNACK PHARMACEUTICALS

Live / Registered — Registered (as of 26 Oct 2021)

What this means for you

Registered since 26 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87818037
Registration number
6540125
Mark type
Design + words
Filed
02 Mar 2018
Published for opposition
24 Jul 2018
Registered
26 Oct 2021
Attorney of record
Tomas Maria Casalins

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives

Owner

Prosecution history

  • 21 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 21 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 21 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 11 Jul 2023 — COUNTERCLAIM OPP. NO. 999999
  • 17 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 17 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 26 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
  • 18 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 17 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 17 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
  • 10 Sept 2021 — USE AMENDMENT FILED
  • 10 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
  • 17 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Marksy